DAVID LE: Open Payments
NPI 1902566458 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 20 payments from 14 companies in 2025. Trend: 2023 $77 · 2024 $751 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $184 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Hologic Sales and Service, LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $34 |
| ABBVIE INC. | 1 | $30 |
| SANOFI PASTEUR INC. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Organon LLC | 1 | $23 |
Products named: FREESTYLE LIBRE 3, SHINGRIX, VRAYLAR, UZEDY, BEYFORTUS, CAPLYTA, PREVNAR 20, APTIMA.
Industry payments across MO — which companies pay providers there.
